New frontiers in the treatment and prevention of migraine: A closer look at the role of emerging GCRP targeted therapies

Research output: Contribution to journalArticlepeer-review

Abstract

Migraine is a common neurologic disorder that significantly impacts a patient’s quality of life and ability to work and is costly to treat. Although numerous agents have been available for preventing migraine, none was specifically designed to target the underlying pathologic process. The new class of agents is targeting one of these underlying pathologic processes.

Original languageEnglish (US)
Pages (from-to)13-19
Number of pages7
JournalJournal of Managed Care Medicine
Volume22
Issue number2
StatePublished - 2019

ASJC Scopus subject areas

  • Health Policy

Fingerprint

Dive into the research topics of 'New frontiers in the treatment and prevention of migraine: A closer look at the role of emerging GCRP targeted therapies'. Together they form a unique fingerprint.

Cite this